| Property | Value |
|
overview
|
Anjana Pillai, MD, is a board-certified gastroenterologist and transplant hepatologist who specializes in managing chronic liver diseases, complex liver transplants and hepatobiliary malignancies. She is the Medical Director of the Transplant Institute and of the Adult Liver Transplant Program. In addition, in her role as the Director of the liver tumor program, Dr. Pillai leads a team of specialists with expertise in benign and malignant liver tumors who together see patients in one location to enhance the patient experience. As a professor of medicine and surgery and a full member of the University of Chicago Medicine Comprehensive Cancer Center, she collaborates with the cancer center to provide individualized treatment options to her patients.
Dr. Pillai is also active in national and international societies that focus on advancing research and setting industry standards, including the UNOS National Liver Review Board for adult HCC and the Governing Board for the International Liver Cancer Association (ILCA). She is the past Chair of the Liver and Intestinal Community of Practice (LICOP) Executive Committee of the American Society of Transplantation (AST) and is the current chair of the Liver Cancer Special Interest Group of the American Association for the Study of Liver Diseases (AASLD). Additionally, she is the Founder and course director of HCC-LIVE, an annual conference dedicated to advancing liver cancer care. Her contributions to these organizations help shape the future of liver transplantation, liver cancer and ensure her patients benefit from the latest medical research.
|